High Prevalence of Antibodies to Calreticulin of the IgA Class in Primary Biliary Cirrhosis: a Possible Role of Gut-Derived Bacterial Antigens in Its Aetiology?

References

• Kaufmann SHE. Heat shock proteins and the immune response. Immunol Today 1990;11:129–36.
   PubMedGoogle Scholar
• Burroughs AK, Butler P, Sternberg MJE, Baum H. Molecular mimicry in liver disease. Nature 1992;358:377–8.
   PubMed Web of Science ®Google Scholar
• Van Eden W, van der Zee R, Paul AGA, Prakken BJ, Wendling U, Anderton SM, et al. Do heat shock proteins control the balance of T-cell regulation in inflammatory diseases? Immunol Today 1998;19:303–7.
   PubMedGoogle Scholar
• Rokeach LA, Haselby JA, Meilof JF, Smeenk RJT, Unnasch TR, Greene BM, et al. Characterization of the autoantigen calreticulin. J Immunol 1991;147:3031–9.
   PubMed Web of Science ®Google Scholar
• Michalak M, Milner RE, Burns K, Opas M. Calreticulin. Biochem J 1992;285:681–92.
   PubMed Web of Science ®Google Scholar
• Sontheimer RD, Lieu TS, Capra JD. Calreticulin. The diverse functional repertoire of a new human autoantigen. Immunologist 1993;1/5:155–60.
   Google Scholar
• Nauseef WM, McCormick SJ, Clark RA. Calreticulin functions as a molecular chaperone in the biosynthesis of myeloperoxidase. J Biol Chem 1995;270:4714–47.
   Google Scholar
• Conway EM, Liu L, Nowakowski B, Steiner-Mosonyi M, Ribeiro SP, Michalak M. Heat shock-sensitive expression of calreticulin. In vitro and in vivo up-regulation. J Biol Chem 1995;270:17011–6.
   Google Scholar
• Kuznetsov G, Nigam SK. Folding of secretory and membrane proteins. N Engl J Med 1998;339:1688–95.
   PubMed Web of Science ®Google Scholar
• Van PG, Peter F, Soeling H-D. Four intracisternal calciumbinding glycoproteins from rat liver microsomes with high affinity for calcium. J Biol Chem 1989;264:17494–501.
   Google Scholar
• Boehm J, Orth T, van Nguyen P, Soeling HD. Systemic lupus erythematosus is associated with increased auto-antibody titers against calreticulin and Grp94, but calreticulin is not the Ro/SS- A antigen. Eur J Clin Invest 1994;24:248–57.
   PubMed Web of Science ®Google Scholar
• Kishore U, Sontheimer RD, Sastry KN, Zappi EG, Hughes GRV. The systemic lupus erythematosus (SLE) diseases autoantigen—calreticulin can inhibit C1q association with immune complexes. Clin Exp Immunol 1997;108: 181–90.
   Google Scholar
• Routsias JG, Tzioufas AG, Sakarellos-Daitsiotis M, Sakarellos C, Moutsopoulos HM. Calreticulin synthetic peptide analogues: anti-peptide antibodies in autoimmune rheumatic diseases. Clin Exp Immunol 1993;91:437–41.
   Google Scholar
• Khalife J, Trottein F, Schacht AM, Godin C, Pierce RJ, Capron A. Cloning of the gene encoding a Schistosoma mansoni homologue to human Ro/SS-A autoantigen. Mol Biochem Parasitol 1993;57:193–202.
   PubMed Web of Science ®Google Scholar
• Kenna JG. Immunoallergic drug-induced hepatitis: lessons from halothane. J Viral Hepatitis 1997;26 Suppl 1:5–12.
   Google Scholar
• Max H, Halder T, Kalbus M, Gnau V, Jung G, Kalbacher H. A 16mer peptide of the human autoantigen calreticulin is a most prominent HLA-DR4Dw4-associated self-peptide. Hum Immunol 1994;41:39–45.
   PubMed Web of Science ®Google Scholar
• Verreck FA, Elferink D, Vermeulen CJ, Amons R, Breedveld F, de Vries RR, et al. DR4Dw4/DR53 molecules contain a peptide from the autoantigen calreticulin. Tissue Antigens 1995;45: 270–5.
   Google Scholar
• Kreisel W, Siegel A, Bahler A, Koehler G, Spamer C, Berg PA, et al. Anti-calreticulin antibodies in autoimmune liver diseases [abstract]. J Hepatol 1996;25 Suppl 1:184.
   Google Scholar
• Heathcote Y. The clinical expression of primary biliary cirrhosis. Semin Liver Dis 1996;17:23–33.
   Web of Science ®Google Scholar
• Leung PSC, Coppel RL, Ansari A, Munoz S, Gershwin ME. Antimitochondrial antibodies in primary biliary cirrhosis. Semin Liver Dis 1997;17:61–9.
   PubMed Web of Science ®Google Scholar
• Johnson PJ, McFarlane IG. Meeting Report: International Autoimmune Hepatitis Group. Hepatology 1993;18:998–1005.
   PubMed Web of Science ®Google Scholar
• Kist M. Yersiniosis. In: Thomas L, Whiocher JT, editors. Clinical laboratory diagnostics: use and assessment of clinical laboratory results. Frankfurt/Main, Germany: TH-Books Verlagsgesellschaft mbH; 1998. p. 1213–7.
   Google Scholar
• Heilmann C, Spamer C, Leberer E, Gerok W, Michalak M. Human liver calreticulin: characterization and Zn2+ -dependent interaction with phenyl-Sepharose. Biochem Biophys Res Commun 1993;193: 511–616.
   Google Scholar
• Laemmli UK. Cleavage of structural proteins during the assembly of the head of the bacteriophage T4. Nature 1970; 227:680–5.
   PubMed Web of Science ®Google Scholar
• Towbin H, Staehlin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979;76:4350–4.
   Google Scholar
• Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193:265–75.
   PubMed Web of Science ®Google Scholar
• Bjarnason I, Peters TJ. Intestinal permeability, non-steroidal anti-inflammatory drug enteropathy and inflammatory bowel disease: an overview. Gut 1989;30:22–8.
   PubMed Web of Science ®Google Scholar
• Van de Wiel A, van Hattum J, Schuurman HJ, Kater I. Immunoglobulin A in the diagnosis of alcoholic liver disease. Gastroenterology 1988;94:457–62.
   PubMed Web of Science ®Google Scholar
• Keshavarzian A, Holmes EW, Patel M, Iber F, Fields JZ, Pethkar S. Leaky gut in alcoholic cirrhosis: a possible mechanism for alcohol-induced liver damage. Am J Gastroenterol 1999;94:200–7.
   PubMed Web of Science ®Google Scholar
• Hartland EL, Robins-Browne RM. Infections with enteropathogenic Yersinia species: paradigms of bacterial pathogenesis. Rev Med Microbiol 1998;9:191–205.
   Web of Science ®Google Scholar
• Burroughs AK, Rosenstein IJ, Epstein O, Hamilton-Miller JM, Brumfit W, Sherlock S. Bacteriuria and primary biliary cirrhosis. Gut 1984;25:133–7.
   Google Scholar
• Butler P, Valle F, Hamilton-Miller JMT, Brumfit W, Baum H, Burroughs AK. M2 mitochondrial antibodies and urinary rough mutant bacteria in patients with primary biliary cirrhosis and in patients with recurrent bacteriuria. J Hepatol 1993;17: 408–14.
   Google Scholar
• Hopf U, Möller B, Stemer owicz R, Lobeck H, Rodloff A, Freudenberg M, et al. Escherichia coli rough (R) mutants in the gut and lipid A in the liver from patients with primary biliary cirrhosis (PBC). Lancet 1989;2:1419–22.
   PubMed Web of Science ®Google Scholar
• O’Donohue J, McFarlane B, Bomford A, Yates M, Williams R. Antibodies to atypical mycobacteria in primary biliary cirrhosis. J Hepatol 1994;21:887–9.
   Google Scholar
• Vilagut L, Parés A, Vinas O, Vila J, Jimenez De Anta MT, et al. Antibodies to mycobacterial 65-kD heat shock protein crossreact with the main mitochondrial antigens in patients with primary biliary cirrhosis. Eur J Clin Invest 1997;27:667–72.
   Google Scholar
• O’Donohue J, Fidler H, Garcia-Barcelo M, Nouri-Aria K, Williams R, McFadden J. Mycobacterial DNA not detected in liver sections from patients with primary biliary cirrhosis. J Hepatol 1998;28:433–8.
   Google Scholar
• Mason AL, Xu L, Guo L, Munoz S, Jaspan JB, Bryer-Ash M, et al. Detection of retroviral antibodies in primary biliary cirrhosis and other idiopathic biliary disorders. Lancet 1998;351:1620–4.
   Google Scholar
• Yamaguchi H, Miura H, Ohsumi K, Ishimi N, Taguchi H, Ishiyama N, et al. Detection and characterization of antibodies to bacterial heat-shock protein 60 in sera of patients with primary biliary cirrhosis. Microbiol Immunol 1994;38:483–7.
   PubMed Web of Science ®Google Scholar
• Wenzel BE, Heesemann J, Heufelder A, Franke TF, Grammerstorf S. Enteropathogenic Yersinia enterocolitica and organ-specific autoimmune diseases in man. Contrib Microbiol Immunol 1991;12:80–8.
   Google Scholar
• Toivanen P, Toivanen A. Does Yersinia induce autoimmunity? Int Arch Allergy Immunol 1994;104:107–11.
   PubMed Web of Science ®Google Scholar
• Whortington MG, O’Donnell KF, Dowling JJ, Murphy T, Whitmore EL. Granulomatous hepatitis in Yersinia enterocolitica bacteraemia. J Infection 1984;9:170–3.
   PubMed Web of Science ®Google Scholar
• Saebø A, Lassen J. Acute and chronic liver disease associated with Yersinia enterocolitica infection: a Norwegian 10-year follow-up study of 458 hospitalized patients. J Intern Med 1992;231: 531–5.
   Google Scholar
• Ide T, Sata M, Nakano H, Suzuki H, Tanikawa K. Increased serum IgM class anti-lipid A antibody and therapeutic effect of ursodeoxycholic acid in primary biliary cirrhosis. Hepatogas- troenterology 1997;44:1569–73.
   Google Scholar
• Tsuneyama K, Yasashima M, Harada K, Hiramatsu K, Gershwin ME, Nakanuma Y. Increased CD1d expression on small bile duct epithelium and epitheloid granuloma in livers in primary biliary cirrhosis. Hepatology 1998;28:620–3.
   PubMed Web of Science ®Google Scholar
• McMillan SA, Haughton dJ, Biggart JD, Edgar JD, Porter KG, McNeill TA. Predictive value for coeliac disease of antibodies to gliadin, endomysium, and jejunum in patients attending for jejunal biopsy. Br Med J 1991;303:1163–5.
   Google Scholar
• Dieterich W, Ehnis T, Bauer M, Donner P, Volta U, Riecken EO, et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 1997;3:797–801.
   PubMed Web of Science ®Google Scholar